TAF
APEN

Tredje AP-fonden’s Apollo Endosurgery, Inc. APEN Stock Holding History

Tredje AP-fonden’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-76,241
Closed -$851K – 586
2017
Q1 		$851K Buy
76,241
+42,408
+125% +$540K 0.03% 454
2016
Q4 		$557K Buy
+33,833
New +$515K 0.02% 475

Other funds holding APEN

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RWA
Ropes Wealth Advisors Boston, Massachusetts $515M AUM 21.76% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Tredje AP-fonden's APEN Position: Q2 2017 in Review

Tredje AP-fonden sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2017, closing a stake of 76,241 shares — an estimated $851K sold.

Tredje AP-fonden first reported a position in APEN in Q4 2016 and held it in 2 quarters. The position peaked at $851K in Q1 2017. 7 funds tracked by Wall St. Rank hold APEN as of Q2 2017.

  • Tredje AP-fonden reported no remaining Apollo Endosurgery, Inc. position as of Q2 2017 after selling out during the quarter.
  • Tredje AP-fonden sold 76,241 Apollo Endosurgery, Inc. shares in Q2 2017, an estimated $851K.
  • Tredje AP-fonden first reported a position in Apollo Endosurgery, Inc. in Q4 2016 and held it in 2 quarters.
  • Tredje AP-fonden's Apollo Endosurgery, Inc. position peaked at $851K in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2017.

Based on Tredje AP-fonden's 13F filing for Q2 2017, filed 10 Aug 2017.